News Focus
News Focus
Followers 147
Posts 26195
Boards Moderated 0
Alias Born 04/08/2004

Re: GrassyKnoll post# 226336

Monday, 04/30/2018 7:07:50 PM

Monday, April 30, 2018 7:07:50 PM

Post# of 405181
Grassyknoll, I agree!!!

The 502B pathway is straightforward. It is possible at the company is in talks with the FDA about evidence in the data needed for approval at this time with no more studies. With approval and superior efficacy the company may be able to go directly to market finding only a partner for sales and distribution. A similar path way may be in the works for BROM. As well as the forSP. That’s three lotto tickets bought and paid for just waiting for the man to pull the ping-pong balls out of the box.



Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y